← Every firm
Meitheal Pharmaceuticals, Inc FDA Recalls
3 recalls on file across drugs, 1 of them Class I and 1 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Class IIFeb 9, 2026Defective Delivery System: Missing or duplicated needles wit |
| Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, Class IIISep 3, 2021Failed Impurities/Degradation Specifications |
| Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 xClass IJan 27, 2021Labeling: Label mix-up: Carton of Cisatracurium Besylate Inj |